Tirzepatide 20mg – dual GIP/GLP-1 receptor agonist twincretin (CAS 2023788-19-2, MW 4,813.5 Da, ~5-day half-life) studied in preclinical metabolic research for incretin signalling, glycaemic regulation, and adipose biology. ≥98% purity.
Tirzepatide 20mg – dual GIP/GLP-1 receptor agonist twincretin (CAS 2023788-19-2, MW 4,813.5 Da, ~5-day half-life) studied in preclinical metabolic research for incretin signalling, glycaemic regulation, and adipose biology. ≥98% purity.
